Scotts Miracle-gro CO Form 4 insider transactions

NYSE
Adam Hanft, a director at Scotts Miracle-Gro, amended a previous SEC filing to correct the number of shares acquired in a transaction on January 31, 2025.
NYSE
Mark D. Kingdon, a director of Scotts Miracle-Gro, filed an amendment to a previous Form 4, correcting the number of shares acquired in a transaction on January 31, 2025.
NYSE
Peter E. Shumlin, a director of Scotts Miracle-Gro, amended a previous SEC filing to correct the number of common shares acquired on January 31, 2025, reporting 3,665 shares instead of the originally stated 4,662.
NYSE
Edith Aviles, a director at Scotts Miracle-Gro, amended a previous SEC filing to correct the number of shares acquired on January 31, 2025.
NYSE
Stephen L. Johnson, a director at Scotts Miracle-Gro, filed an amended SEC Form 4/A to correct the number of shares acquired in a transaction on January 31, 2025.
NYSE
Nick Miaritis, a director at Scotts Miracle-Gro, filed an amended SEC Form 4/A to correct the number of shares acquired in a recent transaction.
NYSE
Roberto Candelino, a director at Scotts Miracle-Gro, filed an amendment to a previous Form 4, correcting the number of shares acquired in a transaction on January 31, 2025.
NYSE
David C. Evans, a director at Scotts Miracle-Gro, amended a previous Form 4 filing to correct the number of shares acquired on January 31, 2025.
NYSE
Mark J. Scheiwer, Interim CFO & CAO of Scotts Miracle-Gro, reports a transaction involving common shares on February 4, 2025.
NYSE
Director John R. Vines reports a transaction involving Scotts Miracle-Gro Co. common shares and dividend equivalent rights.
NYSE
Director Adam Hanft reports the vesting of restricted stock units into common shares of Scotts Miracle-Gro.
NYSE
Director Peter Shumlin reports the conversion of restricted stock units into common shares of Scotts Miracle-Gro Co.
NYSE
Director David C. Evans exercised dividend equivalent rights, acquiring 198 common shares of Scotts Miracle-Gro on February 4, 2025.
NYSE
Director Brian E. Sandoval exercised dividend equivalent rights converting into 150 common shares of Scotts Miracle-Gro on February 4, 2025.
NYSE
Katherine Hagedorn Littlefield, a director and potential 10% owner of Scotts Miracle-Gro Co., reports changes in her beneficial ownership of common shares and derivative securities.
NYSE
Director Stephen L. Johnson reports a transaction involving Scotts Miracle-Gro common shares on February 4, 2025.
NYSE
Dimiter Todorov, EVP, CLO & Corporate Secretary of Scotts Miracle-Gro, reported the disposal of 340 common shares to cover tax obligations.
NYSE
James Hagedorn, Chairman & CEO of Scotts Miracle-Gro, reports a disposition of shares to cover tax obligations and updates to beneficial ownership.
NYSE
Christopher Hagedorn, EVP & Chief of Staff at Scotts Miracle-Gro, reports the disposal of 1,951 common shares to cover tax obligations.
NYSE
Director Adam Hanft reports changes in beneficial ownership of Scotts Miracle-Gro (SMG) common shares due to an acquisition and disposal on January 31, 2025.
NYSE
Nathan Eric Baxter, President and COO of Scotts Miracle-Gro, acquired 10,749 stock options on January 31, 2025.
NYSE
Director David C. Evans reports acquiring 3,765 common shares of Scotts Miracle-Gro on January 31, 2025.
NYSE
Director John R. Vines reports acquisition and disposal of Scotts Miracle-Gro (SMG) common shares on January 31, 2025.
NYSE
Christopher Hagedorn, EVP & Chief of Staff at Scotts Miracle-Gro, acquired 5,375 stock options on January 31, 2025.
NYSE
Director Stephen L. Johnson reports acquisition and disposal of Scotts Miracle-Gro (SMG) common shares and deferred stock units.
NYSE
Director Edith Aviles of Scotts Miracle-Gro Co. reports acquiring 3,765 common shares and disposing of 11,502 common shares on January 31, 2025.
NYSE
Director Brian E. Sandoval of Scotts Miracle-Gro acquired common shares and deferred stock units on January 31, 2025.
NYSE
Dimiter Todorov, EVP, CLO & Corporate Secretary at Scotts Miracle-Gro, acquired 1,613 stock options on January 31, 2025.
NYSE
A Form 4 filing reveals that a director at Scotts Miracle-Gro, Mark D. Kingdon, acquired 3,765 common shares on January 31, 2025.
NYSE
Mark J. Scheiwer, Interim CFO & CAO of Scotts Miracle-Gro, was granted 7,524 stock options on January 31, 2025.